Plant Cell / Karolinska Institute / Flanders Interuniversity Institute / National Public Health Institute / Genetic Facility / Proteomics Facility / Brandeis University / University of Ghent / Free University of Brussels / /
IndustryTerm
performant bio high tech cluster / biotechnology / thight network / biotech communication network / selected research groups / structured technology transfer process / exploratory technologies / gene technology research / food / industrial network / public information / Flemish and foreign venture capital investors / pro-active technology transfer policy / scientific management / venture capital firms / research groups / spin-off / technology transfer / /
Organization
Brandeis University / Free University of Brussels / Jan Cornelis Centre / Flanders Interuniversity Institute for Biotechnology / Department of Molecular Microbiology / University of Ghent / National Public Health Institute / Department of Molecular Microbiology International / European Commission / Karolinska Institute / Stockholm / /
Person
Fotis Kafatos / Michèle Oleo / Biomedicum / André De Leenheer / Fotis C. Kafatos / James Watson / Gregory Petsko / Dirk Inzé / Daniel Louvard / Jo Bury / Richard Flavell / Joël Vandekerckhove / Van Reet / Leena Peltonen / Roger Bouillon / Albert Van Loo / Hans Witgzell / Frans Van Roy / Hugo Van Heuverswyn / Gerard Van Acker / Børge Diderichsen / Rudy Dekeyser / Francis Crick / Hans Wigzell / Johan Thevelein / /
Position
General Director / President / Vice President / General management / Director / Institut Curie / group leader / Chairman / board of directors Preface / Professor / General research Foundations / Chair / Research Director / Director / EMBL / chairman of the board of directors / /
Annual Report 2003 VIB activities in 2002 Highlights of 2002 At the beginning of 2002, VIB entered into the second management agreement with